Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy

Table 4

Comparison of MIB 1 LI*.

MIB LI*	US-CT group (𝑛=50)	NACT group (𝑛=50)	P value
≤30%	16 (32%)	41 (82%)	0.001
31–60%	29 (58%)	7 (14%)
>60%	5 (10%)	2 (4%)

∗LI: labeling index.